Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ECIA
Encision
$0.04
$0.06
$0.00
▼
$0.39
$690K-7.582,080 shsN/A
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
$0.17
-6.8%		$0.37
$0.16
▼
$3.20
$2.55M-1.032.24 million shs884,141 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$0.18
+6.7%		$0.33
$0.16
▼
$3.82
$2.36M6.0432.30 million shs2.65 million shs
VYCO
Vycor Medical
$0.07
+0.3%		$0.07
$0.03
▼
$0.20
$2.24M-0.5313,163 shs127,000 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ECIA
Encision
0.00%0.00%-4.92%+5,700.00%-88.33%
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
-6.78%-16.07%-43.69%-84.29%-93.24%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
+6.70%+4.01%-42.29%-68.25%-95.23%
VYCO
Vycor Medical
+0.30%+0.30%-2.61%-3.72%-47.91%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ECIA
Encision
$0.04
$0.06
$0.00
▼
$0.39
$690K-7.582,080 shsN/A
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
$0.17
-6.8%		$0.37
$0.16
▼
$3.20
$2.55M-1.032.24 million shs884,141 shs
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$0.18
+6.7%		$0.33
$0.16
▼
$3.82
$2.36M6.0432.30 million shs2.65 million shs
VYCO
Vycor Medical
$0.07
+0.3%		$0.07
$0.03
▼
$0.20
$2.24M-0.5313,163 shs127,000 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ECIA
Encision
0.00%0.00%-4.92%+5,700.00%-88.33%
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
-6.78%-16.07%-43.69%-84.29%-93.24%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
+6.70%+4.01%-42.29%-68.25%-95.23%
VYCO
Vycor Medical
+0.30%+0.30%-2.61%-3.72%-47.91%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ECIA
Encision
0.00
N/AN/AN/A
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
0.00
N/AN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.25
Hold$2.801,441.85% Upside
VYCO
Vycor Medical
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ECIA, VTAK, VVOS, and VYCO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ECIA
Encision
$5.78M0.12N/AN/A$0.08 per share0.51
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
$820K2.90$5.50 per share0.03$3.82 per share0.04
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
$17.44M0.14N/AN/A($0.16) per share-1.14
VYCO
Vycor Medical
$1.86M1.21N/AN/A($0.12) per share-0.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ECIA
Encision
-$720K-$0.03N/AN/AN/AN/AN/AN/AN/A
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
-$17.18MN/AN/AN/AN/A-656.03%-37.53%-13.05%11/12/2026 (Estimated)
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$21.17M-$1.90N/AN/AN/A-122.00%-2,325.64%-102.01%11/18/2026 (Estimated)
VYCO
Vycor Medical
-$70KN/AN/AN/AN/A-3.30%N/A-4.70%N/A

Latest ECIA, VTAK, VVOS, and VYCO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
-$19.00-$0.92+$18.08-$0.92$2.00 million$1.02 million
8/14/2026Q2 2026
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
-$0.41-$0.31+$0.10-$0.31$5.63 million$5.15 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ECIA
Encision
N/AN/AN/AN/AN/A
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
N/AN/AN/AN/AN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/AN/AN/AN/AN/A
VYCO
Vycor Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ECIA
Encision
0.10
1.74
0.69
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
0.19
0.19
0.18
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
N/A
0.21
0.21
VYCO
Vycor Medical
N/A
0.13
0.09

Institutional Ownership

CompanyInstitutional Ownership
ECIA
Encision
8.20%
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
20.34%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
26.35%
VYCO
Vycor Medical
N/A

Insider Ownership

CompanyInsider Ownership
ECIA
Encision
36.75%
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
5.89%
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
2.10%
VYCO
Vycor Medical
7.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
ECIA
Encision
3016.88 million10.68 millionNot Optionable
Catheter Precision, Inc. stock logo
VTAK
Catheter Precision
1414.39 million13.54 millionN/A
Vivos Therapeutics, Inc. stock logo
VVOS
Vivos Therapeutics
16013.90 million13.60 millionOptionable
VYCO
Vycor Medical
633.42 million31.07 millionNot Optionable

Recent News About These Companies

Vycor Medical Releases Financial Results for the Three Months Ended March 31, 2026
June 14, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/TheNewswire.com/1963818/vycor-medical-releases-financial-results-for-the-three-months-ended-march-31-2026/
EQS-News: Vycor Medical, Inc.: Vycor Medical Releases Financial Results for the Three Months Ended March 31, 2026
May 16, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68512704-eqs-news-vycor-medical-inc-vycor-medical-releases-financial-results-for-the-three-months-ended-march-31-2026-023.htm
Vycor Medical Releases Financial Results for the Year Ended December 31, 2025
March 31, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/vycor-medical-releases-financial-results-185314037.html
Vycor Medical Posts 22 Percent Q2 Growth
August 9, 2025  |  aol.comA
New Study on NovaVision's NeuroEyeCoach Shows Significant Benefits for Patients in Home or Clinic Setting
July 8, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/study-novavisions-neuroeyecoach-shows-significant-123000350.html
VYCO Vycor Medical, Inc.
May 31, 2025  |  seekingalpha.comhttps://seekingalpha.com/symbol/VYCO
Vycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor Base
March 14, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/vycor-medical-joins-b2i-digital-161352247.html
EQS-News: Vycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor Base
March 13, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/eqs-news-vycor-medical-joins-b2i-digital-venture-company-program-to-build-and-educate-its-investor-base-1034475281
Medical ethics articles from across Nature Portfolio
October 22, 2024  |  nature.comN
BlueChew Review 2024
January 17, 2024  |  medicalnewstoday.comM
What to know about bleeding hemorrhoids
December 19, 2023  |  medicalnewstoday.comM
Common symptoms of depression: What to know
October 11, 2023  |  medicalnewstoday.comM
Vycor Medical, Inc. (VYCO)
January 7, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/quote/VYCO/history
Medical Review Board
November 1, 2022  |  health.usnews.comhttps://health.usnews.com/medical-board
Medical Scholars Program
September 12, 2022  |  slu.eduS
Vycor Medical Inc
September 8, 2022  |  reuters.comhttps://www.reuters.com/markets/companies/VYCO.PK
Minnetronix commercializes its own product: a minimally invasive deep brain access port
August 20, 2022  |  medcitynews.comM
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions
May 11, 2022  |  nice.org.ukN
Vycor Medical Year to Date Total Returns (Daily)
January 2, 2022  |  ycharts.comY
Vycor Medical Inc (VYCO)
December 17, 2021  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/vyco/institutional-holdings?random=61b9e8a7b66b6

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Nvidia logo illuminated in green on a circuit board background with glowing data connection lines.
NVIDIA's $500 Billion GPU Financing Deal Fuels Path Toward $270
By Thomas Hughes | August 14, 2026
Model ship and stacked coins beside a tablet showing a Vanguard VTSAX portfolio summary and growth chart on a desk.
VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
By Jessica Mitacek | August 23, 2026
Five Below store display with logo sign above shelves of tumblers, socks, sunglasses, backpacks, and $5 priced items.
Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
By Peter Frank | August 27, 2026
Curaleaf logo displayed with cannabis leaves and a bud on a reflective surface against a dark green background.
Joint Operations: Curaleaf Makes a Play for Aurora Cannabis
By Jeffrey Neal Johnson | August 14, 2026
Vertiv logo displayed in a data center aisle lined with server racks and power equipment.
Vertiv’s UIG Deal Targets the Next Big Constraint in AI Data Centers
By Chris Markoch | September 4, 2026

Encision OTCMKTS:ECIA

$0.04 0.00 (0.00%)
As of 09/9/2026

Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.

Catheter Precision stock logo

Catheter Precision NYSEAMERICAN:VTAK

$0.16 -0.01 (-6.78%)
Closing price 09/10/2026 04:10 PM Eastern
Extended Trading
$0.17 +0.01 (+4.24%)
As of 05:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. The company sells it products through distribution partners, independent sales agents, and direct employees. Catheter Precision, Inc. is based in Fort Mill, South Carolina.

Vivos Therapeutics stock logo

Vivos Therapeutics NASDAQ:VVOS

$0.18 +0.01 (+6.70%)
Closing price 09/10/2026 04:00 PM Eastern
Extended Trading
$0.18 -0.01 (-3.08%)
As of 05:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Vycor Medical OTCMKTS:VYCO

$0.07 +0.00 (+0.30%)
As of 09/10/2026 01:26 PM Eastern

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas